Stock Taper 
NTRB
$4.46
▼ DOWN 3.46% (-0.16)
KEY STATISTICS
Market Cap$54.22 M
52w High$8.63
52w Low$2.80
Dividend Yield—
Frequency—
P/E-1.87
Volume6.58K
Shares Out.12.16M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Gareth Sheridan
COMPENSATION 2026
Salary$150,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$5,000
Total$358,368
ABOUT
SECTOR
Healthcare
WENT PUBLIC
October 1, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
13
UPCOMING EARNINGS
DateSep 30, 2026
DayWednesday
Rev. Est.—
SEP
30
WED
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2022-08-15 | Forward | 7:6 |
| 2022-08-12 | Forward | 583:500 |
| 2019-07-24 | Reverse | 1:4 |
PRICE
$4.46 ▼ DOWN 3.46% (−$0.16)About Nutriband Inc.
https://nutriband.com ↗Nutriband Inc. develops transdermal pharmaceutical products, including abuse-deterrent fentanyl, buprenorphine, methylphenidate, and treatments for diabetes and infertility, with a license for closed system transfer devices.
INDUSTRY
Biotechnology
A PRODUCT NUTRIBAND INC. IS KNOWN FOR
AVERSA Fentanyl
AVERSA Fentanyl is Nutriband's lead abuse-deterrent transdermal patch designed to prevent misuse and abuse of fentanyl, with the potential to be the first globally approved product using proprietary AVERSA™ technology.
Revenue by Products
| Icon | PRODUCT | Q1-2022 |
|---|---|---|
 | TransdermalPatchesMember | $401.99K |
 | ContractServicesMember | $75.93K |
Revenue by Geography
| Map | REGION | Q1-2025 | Q2-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|---|
 | UNITED STATES | $667.43K | $614.92K ▼ | $746.67K ▲ | $433.4K ▼ |
 | Foreign Member | — | $7.63K | — | — |
ETFS HOLDING THIS STOCK
ETFS HOLDING
11
LISTED HERE
2
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
3.29%
HOLDERS
26
TOP 12 OF 26 · RANKED BY POSITION SIZE
Vanguard Group Inc
Geode Capital Management, LLC
Ubs Group AG
State Street Corp
Cetera Investment Advisers
Northern Trust Corp
Haven Private, LLC
Blackrock, Inc.
Fieldpoint Private Securities, LLC
Advisor Group Holdings, Inc.
Morgan Stanley
Wells Fargo & Company/Mn
RATINGS SNAPSHOT
Overall rating: C-
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book1
Overall Score1
INSIDER TRADES
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Sheridan Gareth
Purchase · 29.3K shares
2025-01-29
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Sheridan Gareth
— · —
2025-01-31
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Sheridan Gareth
Purchase · 97.5K shares
2024-03-20
★
OFFICER: CHIEF FINANCIAL OFFICER
Goodman Gerald
Purchase · 17.7K shares
2025-01-23
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 RLMD | $4.33 | COMPARE |
 ADAG | $3.68 | COMPARE |
 FBIO | $2.77 | COMPARE |
 ACRV | $2.06 | COMPARE |
 ACET | $9.06 | COMPARE |
 GANX | $1.77 | COMPARE |
 XBIT | $2.27 | COMPARE |
 TCRX | $0.75 | COMPARE |